Company Profiles

driven by the PitchBook Platform

Allakos

Description

Developer of antibody-based therapeutics intended to treat allergic and inflammatory diseases.The company's antibody-based therapeutics utilizes a pipeline of antibodies that target cell types implicated in allergic and inflammatory responses.

2012

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$42M

Latest Deal Amount

$42M

Total Amount Raised

Description

Developer of antibody-based therapeutics intended to treat allergic and inflammatory diseases.The company's antibody-based therapeutics utilizes a pipeline of antibodies that target cell types implicated in allergic and inflammatory responses.

Website:

www.allakos.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

75 Shoreway Road San Carlos, CA 94070United States +1 (650) 597-5002
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Allakos's full profile, request a free trial.

Allakos Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Allakos Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Allakos Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alta PartnersVenture CapitalMinority000 0000000 0000
De Novo VenturesVenture CapitalMinority000 0000000 0000
InterWest Healthcare PartnersVenture CapitalMinority000 0000000 0000
NovoCorporate Venture CapitalMinority000 0000000 0000
RiverVest Venture PartnersVenture CapitalMinority000 0000000 0000
Alta Partners Venture Capital
De Novo Ventures Venture Capital
InterWest Healthcare Partners Venture Capital
Novo Corporate Venture Capital
RiverVest Venture Partners Venture Capital

Allakos Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Christopher Bebbington Ph.DCo-Founder, Board Member, President & Chief Executive Officer
Simon Greenwood Ph.DChief Business Officer
Omer SiddiquiVice President, Clinical Operations
Sally Bolmer Ph.DVice President, Regulatory Affairs and Drug Development
Nenad Tomasevic Ph.DVice President, Research
Christopher Bebbington Ph.D Co-Founder, Board Member, President & Chief Executive Officer
Simon Greenwood Ph.D Chief Business Officer
Omer Siddiqui Vice President, Clinical Operations
Sally Bolmer Ph.D Vice President, Regulatory Affairs and Drug Development
Nenad Tomasevic Ph.D Vice President, Research

Allakos Board Members (5)

NameRepresentingRoleSinceContact
Info
Carole Nuechterlein JDRoche Venture FundHead000 0000
Farah ChampsiInterWest Healthcare PartnersManaging Director000 0000
John McKearn Ph.DRiverVest Venture PartnersManaging Director000 0000
Peter Moldt Ph.DNovoPartner, Novo Ventures000 0000
Steven JamesSelfBoard Member000 0000
Carole Nuechterlein JD Head Roche Venture Fund
Farah Champsi Managing Director InterWest Healthcare Partners
John McKearn Ph.D Managing Director RiverVest Venture Partners
Peter Moldt Ph.D Partner, Novo Ventures Novo
Steven James Board Member Self
Request full access to PitchBook